The U.S. Centers for Disease Control and Prevention (CDC) awarded a $460,000 Cooperative Agreement under CFDA 93.376 "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" to the Young Survival Coalition, Inc. The 5-year award period runs from September 30, 2024 to September 29, 2029. The grant supports the development and delivery of comprehensive psychosocial and structural support services for young breast cancer survivors and metastatic...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $460,000 Cooperative Agreement under CFDA 93.376 "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" to the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, MA. The 5-year award, effective September 30, 2024 through September 29, 2029, supports DFCI in providing comprehensive psychosocial and structural support services to improve quality of life for young breast...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the federal grant program titled "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376), provides $1,379,961 in funding to Living Beyond Breast Cancer to support young breast cancer survivors, metastatic breast cancer patients, and their families. The project aims to improve quality of life by increasing access to emotional...
This Cooperative Agreement award from the National Center for Chronic Disease Prevention and Health Promotion (CFDA 93.376 - Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients) provides $460,000.00 in funding over 5 years to Force-Facing Our Risk Of Cancer Empowered, Inc. to support young breast cancer survivors, metastatic breast cancer patients, and their families. The award aims to improve quality of life for these populations by increasing...
The federal Cooperative Agreement award, funded by the Centers for Disease Control and Prevention (CDC) under CFDA 93.376 "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients", provides $460,000.00 in funding to Weill Medical College of Cornell University over a 5-year period from September 30, 2024 to September 29, 2029. The award supports the development and implementation of comprehensive psychosocial and structural support services for...
The Centers for Disease Control and Prevention (CDC) awarded a $460,000 Cooperative Agreement under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) federal grant program. This 5-year award, effective September 30, 2024, will support the Breast Cancer Resource Center in Texas to provide comprehensive psychosocial and structural support services for young breast cancer survivors and metastatic breast cancer...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $156,000.00 to The Medical College of Wisconsin, Inc. to conduct a national cohort study examining breast cancer diagnostics, treatments, and outcomes in individuals on hormone therapy. The key objectives are to: 1) Create a national cohort of patients on hormone therapy with breast cancer from 23 institutions to collect detailed patient demographic, treatment, and outcome...
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $459,993 Cooperative Agreement under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" program (CFDA 93.376) to the University of Illinois. This 5-year award, effective September 30, 2024, will support the University of Illinois in developing and delivering comprehensive psychosocial and structural support services for young...
This Project Grant award for $166,984 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports efforts to increase enrollment of adolescent and young adult (AYA) cancer patients on clinical trials at the Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins University. The project will develop and implement an "AYA: ALERT, Young Adult Navigation, Alliance" system to identify eligible AYA patients, provide them with timely information about...
This $290,052 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports the development and evaluation of a mobile-optimized intervention called PERCS-YA (Personalized Cancer Support for Young Adults) to reduce worry and distress among young adult cancer survivors. The award will fund stakeholder-engaged refinement of the PERCS-YA intervention, followed by a Phase II efficacy trial utilizing both a...